{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7192,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data from GEMINI 1 study; highlights that higher exposure does not necessarily correlate with higher remission rates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/25",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a 2x2 grid to summarize the program's value proposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/26",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide uses peer benchmarking to justify valuation growth expectations based on clinical trial phases.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/27",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table highlights the competitive positioning of SPY001, specifically emphasizing its subcutaneous administration profile.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/28",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-28",
      "loopMatches": [
        {
          "to": 28,
          "from": 28,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "97dc64e0-9ee7-4111-9a96-eee5c2c2a6af",
          "evidence": "The document presents Spyre's plan to rapidly advance combination programs.",
          "position": 2,
          "objective": "What if Spyre's combination programs could create optimal combinations in IBD?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "testimonial",
      "function": "cite_precedent",
      "notes": "The chart compares preference share between Naïve and Switch patients for four different drug profiles.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/29",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style pipeline visualization to show progress from discovery to clinical stages for seven distinct programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/30",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The chart uses a color-coded safety gradient on the Y-axis and efficacy percentages on the X-axis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/31",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a checkmark-based comparison matrix to highlight SPY002's superior profile.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/32",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses an antibody diagram to annotate specific technical improvements (half-life extension and formulation).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/33",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a cross-trial comparison to argue that the superiority of one mechanism over the other is not yet established, supporting a redundant development strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/34",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "product_demo",
      "function": "present_solution",
      "notes": "The slide uses two distinct chart types: a dose-response curve (sigmoidal) and a scatter plot to demonstrate potency and specificity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/35",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a 2x2 grid to summarize the program's value proposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/36",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a mountain-like diagram to represent sequential or cumulative expansion of indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/37",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to show the progression of various IBD programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/38",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological process diagram to illustrate the mechanism of action for three distinct drug candidates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/39",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart to illustrate the additive effect of combining two therapies, with a supporting table for N, maintenance remission, and safety.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/40",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a comparison framework to highlight the competitive advantage of Spyre's gut-selective approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/41",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to illustrate the clinical trial strategy for SPY001 and SPY003.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/42",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a visual representation of a bispecific or combination antibody structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/43",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a Venn diagram to show target overlap and a hierarchical tree diagram to show diagnostic-driven treatment selection.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/44",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 44,
          "from": 10,
          "beatId": "4a77d9e6-a2c5-4533-8a36-dd4f9e373789",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Spyre's pipeline and solution for IBD treatment.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a comparative bar chart structure to validate the efficacy of genetic companion diagnostics (CDx) in improving clinical outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/45",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/46",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide includes a section for Management team and a section for Board of Directors, with headshots and titles for each individual, followed by a logo grid of affiliated organizations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/47",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a table-based timeline structure to map drug candidates (SPY001-004) against expected clinical milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/48",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide uses a custom bar chart visualization within a table to show market cap ranges (Min, IPO, Today, Max).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/49",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table maps historical M&A deal values to Spyre's internal pipeline milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/50",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/51",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide highlights the partnership with Paragon Therapeutics, detailing its founding, team size, operational capacity, program count, and the spin-out of Apogee Therapeutics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/52",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a series of icons to represent different scientific methodologies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/53",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d132-769f-97bd-4a840dd24899",
      "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
      "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
      "authorId": "aeglea-biotherapeutics",
      "authorName": "Aeglea BioTherapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The central graphic is an antibody structure inside a pentagon, representing the five optimization pillars.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/54",
      "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
      "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 56,
          "from": 45,
          "beatId": "a269a747-0743-41c8-a64a-96220e98956c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the potential impact and next steps for Spyre's pipeline.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}